Sulaiman, Maela .

HRN: 26-30-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/29/2024
12/08/2024
PO
3.5ml
TID
Amoebiasis
Waiting Final Action 
11/29/2024
CEFUROXIME 1.5GM (VIAL)
11/29/2024
12/05/2024
IV
270mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: